Regencell Bioscience Stock Forecast - Simple Regression
| RGC Stock | USD 31.41 0.64 2.08% |
Regencell Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Regencell Bioscience stock prices and determine the direction of Regencell Bioscience Holdings's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Regencell Bioscience's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The value of RSI of Regencell Bioscience's share price is at 54 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Regencell Bioscience, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
Using Regencell Bioscience hype-based prediction, you can estimate the value of Regencell Bioscience Holdings from the perspective of Regencell Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Regencell Bioscience Holdings on the next trading day is expected to be 32.70 with a mean absolute deviation of 4.46 and the sum of the absolute errors of 272.01. Regencell Bioscience after-hype prediction price | USD 31.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regencell | Build AI portfolio with Regencell Stock |
Regencell Bioscience Additional Predictive Modules
Most predictive techniques to examine Regencell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regencell using various technical indicators. When you analyze Regencell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Regencell Bioscience Simple Regression Price Forecast For the 26th of January
Given 90 days horizon, the Simple Regression forecasted value of Regencell Bioscience Holdings on the next trading day is expected to be 32.70 with a mean absolute deviation of 4.46, mean absolute percentage error of 38.66, and the sum of the absolute errors of 272.01.Please note that although there have been many attempts to predict Regencell Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Regencell Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Regencell Bioscience Stock Forecast Pattern
| Backtest Regencell Bioscience | Regencell Bioscience Price Prediction | Buy or Sell Advice |
Regencell Bioscience Forecasted Value
In the context of forecasting Regencell Bioscience's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Regencell Bioscience's downside and upside margins for the forecasting period are 19.52 and 45.87, respectively. We have considered Regencell Bioscience's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Regencell Bioscience stock data series using in forecasting. Note that when a statistical model is used to represent Regencell Bioscience stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.7653 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 4.4591 |
| MAPE | Mean absolute percentage error | 0.2248 |
| SAE | Sum of the absolute errors | 272.0054 |
Predictive Modules for Regencell Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regencell Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Regencell Bioscience After-Hype Price Density Analysis
As far as predicting the price of Regencell Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regencell Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regencell Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regencell Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Regencell Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regencell Bioscience's historical news coverage. Regencell Bioscience's after-hype downside and upside margins for the prediction period are 18.23 and 44.59, respectively. We have considered Regencell Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regencell Bioscience is somewhat reliable at this time. Analysis and calculation of next after-hype price of Regencell Bioscience is based on 3 months time horizon.
Regencell Bioscience Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Regencell Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regencell Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regencell Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.80 | 13.18 | 0.00 | 0.57 | 0 Events / Month | 6 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
31.41 | 31.41 | 0.00 |
|
Regencell Bioscience Hype Timeline
On the 25th of January Regencell Bioscience is traded for 31.41. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.57. Regencell is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 1.8%. %. The volatility of related hype on Regencell Bioscience is about 4144.65%, with the expected price after the next announcement by competition of 31.98. About 89.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Regencell Bioscience recorded a loss per share of 0.01. The entity last dividend was issued on the 1st of December 2017. The firm had 38:1 split on the 16th of June 2025. Considering the 90-day investment horizon the next forecasted press release will be within a week. Check out Historical Fundamental Analysis of Regencell Bioscience to cross-verify your projections.Regencell Bioscience Related Hype Analysis
Having access to credible news sources related to Regencell Bioscience's direct competition is more important than ever and may enhance your ability to predict Regencell Bioscience's future price movements. Getting to know how Regencell Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regencell Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CYTK | Cytokinetics | 0.00 | 0 per month | 2.19 | 0.01 | 4.25 | (3.55) | 10.86 | |
| MRUS | Merus BV | 0.52 | 18 per month | 0.00 | (0.17) | 0.32 | (0.21) | 7.73 | |
| ATR | AptarGroup | 0.00 | 0 per month | 0.00 | (0.07) | 1.73 | (2.49) | 6.75 | |
| GRFS | Grifols SA ADR | (0.58) | 22 per month | 0.00 | (0.04) | 3.17 | (3.19) | 8.69 | |
| ABVX | Abivax SA American | 0.00 | 0 per month | 3.45 | 0.09 | 6.94 | (6.09) | 29.38 | |
| RYTM | Rhythm Pharmaceuticals | 4.83 | 11 per month | 0.00 | (0.05) | 4.03 | (5.14) | 18.69 | |
| STVN | Stevanato Group SpA | (0.02) | 4 per month | 0.00 | (0.26) | 4.36 | (4.31) | 15.63 | |
| AXSM | Axsome Therapeutics | 0.82 | 12 per month | 1.23 | 0.15 | 4.20 | (2.36) | 26.78 | |
| NUVL | Nuvalent | (2.37) | 8 per month | 2.73 | 0.03 | 4.63 | (4.96) | 17.52 | |
| MASI | Masimo | (0.02) | 4 per month | 0.00 | (0.06) | 3.06 | (2.71) | 10.00 |
Other Forecasting Options for Regencell Bioscience
For every potential investor in Regencell, whether a beginner or expert, Regencell Bioscience's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Regencell Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Regencell. Basic forecasting techniques help filter out the noise by identifying Regencell Bioscience's price trends.Regencell Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regencell Bioscience stock to make a market-neutral strategy. Peer analysis of Regencell Bioscience could also be used in its relative valuation, which is a method of valuing Regencell Bioscience by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Regencell Bioscience Market Strength Events
Market strength indicators help investors to evaluate how Regencell Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regencell Bioscience shares will generate the highest return on investment. By undertsting and applying Regencell Bioscience stock market strength indicators, traders can identify Regencell Bioscience Holdings entry and exit signals to maximize returns.
Regencell Bioscience Risk Indicators
The analysis of Regencell Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Regencell Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting regencell stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.23 | |||
| Semi Deviation | 8.22 | |||
| Standard Deviation | 13.18 | |||
| Variance | 173.69 | |||
| Downside Variance | 83.15 | |||
| Semi Variance | 67.61 | |||
| Expected Short fall | (10.51) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Regencell Bioscience
The number of cover stories for Regencell Bioscience depends on current market conditions and Regencell Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regencell Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regencell Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Regencell Bioscience Short Properties
Regencell Bioscience's future price predictability will typically decrease when Regencell Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regencell Bioscience Holdings often depends not only on the future outlook of the potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 494.5 M | |
| Cash And Short Term Investments | 4.9 M |
Check out Historical Fundamental Analysis of Regencell Bioscience to cross-verify your projections. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.